AusPAR: Comirnaty COVID-19 Vaccine | Therapeutic Goods Administration (TGA)

AusPAR

AusPAR Comirnaty [PDF, 3.09 MB]

AusPAR Comirnaty [Word, 2.63 MB]

Attachment 1: Product Information Comirnaty [PDF, 930.64 KB]

Attachment 1: Product Information Comirnaty [Word, 1.22 MB]

Attachment 2: Product Information Comirnaty [PDF, 1.62 MB]

Attachment 2: Product Information Comirnaty [Word, 3.8 MB]

Device/Product Name

Comirnaty COVID-19 Vaccine

Active ingredients

Tozinameran

AusPAR Date

7 August 2023

Published

11 August 2023

Submission Number

PM-2023-01183-1-2

Submission Type

Provisional to full registration

Decision

Approved